Skip to main content

NATCO 30 Pill - blue & pink capsule/oblong

Pill with imprint NATCO 30 is Blue & Pink, Capsule/Oblong and has been identified as Lansoprazole Delayed-Release 30 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Lansoprazole is used in the treatment of Barrett's Esophagus; GERD; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Erosive Esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 30

Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30
Lansoprazole delayed-release 30 mg NATCO 30

Lansoprazole Delayed-Release

Imprint
NATCO 30
Strength
30 mg
Color
Blue & Pink
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Inactive Ingredients
acetone, isopropyl alcohol, magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol 4000, polysorbate 80, sucrose, corn starch, magnesium silicate, titanium dioxide, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, water, ammonia, potassium hydroxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
45963-0461 (Discontinued) Actavis Pharma, Inc.
51991-0772 (Discontinued) Breckenridge Pharmaceutical, Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer